The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...
The FDA approved Yuvezzi, a fixed-dose combination eye drop of carbachol and brimonidine tartrate, for the treatment of presbyopia in adult patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results